Details for New Drug Application (NDA): 080380
✉ Email this page to a colleague
NDA 080380 describes BAMATE, which is a drug marketed by Alra and is included in one NDA. Additional details are available on the BAMATE profile page.
The generic ingredient in BAMATE is meprobamate. There are twenty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the meprobamate profile page.
The generic ingredient in BAMATE is meprobamate. There are twenty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the meprobamate profile page.
Summary for 080380
| Tradename: | BAMATE |
| Applicant: | Alra |
| Ingredient: | meprobamate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 080380
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 400MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
